A systematic review finds that following the Mediterranean diet is linked to better physical, mental, and social well-being, particularly in aging populations and those with chronic conditions.
FDA Approves New Agent for Nerve Pain From Rare Inherited Disease
Eplontersen (Wainua) was approved by the FDA to treat polyneuropathy associated with hereditary transthyretin-mediated amyloidosis (ATTR) in adults, Ionis Pharmaceuticals and AstraZeneca announced on Thursday.